TokenPost·
Chemomab Therapeutics Posts $5.1 Million Third-Quarter Net Loss

The loss was less than $0.01 per basic and diluted ordinary share. Cash, cash equivalents and short-term bank deposits totaled $4.7 million as of Sept. 30, 2026.
Every crypto headline. One feed. Updated every minute.

The loss was less than $0.01 per basic and diluted ordinary share. Cash, cash equivalents and short-term bank deposits totaled $4.7 million as of Sept. 30, 2026.